NEW YORK, April 12, 2018 /PRNewswire/ --WallStEquities.com strives to bring the best free research to the investment community.Today we are offering reports on PBH, EYES, SENS, and VAR which can be accessed for free by signing up to www.wallstequities.com/registration. On Wednesday, the NASDAQ Composite ended the day at 7,069.03, down 0.36%; the Dow Jones Industrial Average
Prestige Brands Holdings
Tarrytown, New York headquartered Prestige Brands Holdings Inc.'s stock finished Wednesday's session 1.04% lower at $32.31 with a total trading volume of 594,166 shares. The Company's shares are trading below their 50-day moving average by 8.58%. Moreover, shares of Prestige Brands, which through its subsidiaries, markets, sells, manufactures, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally, have a Relative Strength Index (RSI) of 38.19. Get the full research report on PBH for free by clicking below at:
Second Sight Medical Products
Shares in Sylmar, California headquartered Second Sight Medical Products Inc. declined 1.72%, ending yesterday's session at $1.71 with a total trading volume of 143,740 shares. The stock has gained 48.70% over the past twelve months. The Company's shares are trading above their 200-day moving average by 16.47%. Moreover, shares of the Company, which develops, manufactures, and markets prosthetic devices to restore functional vision to blind individuals in the US, Italy, Germany, France, Canada, and Singapore, have an RSI of 43.26. Gain free access to the research report on EYES at:
On Wednesday, Germantown, Maryland headquartered Senseonics Holdings Inc.'s stock saw a decline of 2.41%, to close the day at $3.65. A total volume of 1.18 million shares was traded, which was higher than their three months average volume of 831.34 thousand shares. The Company's shares have advanced 15.51% in the last month, 22.07% in the previous three months, and 115.98% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 24.33% and 32.68%, respectively. Additionally, shares of Senseonics, which designs, develops, and commercializes glucose monitoring systems for people with diabetes primarily in Europe, have an RSI of 67.15. Register for your free report coverage on SENS at:
Varian Medical Systems
Shares in Palo Alto, California headquartered Varian Medical Systems Inc. ended the day 0.66% lower at $119.14. A total volume of 559,699 shares was traded. The stock has advanced 31.75% over the last twelve months. The Company's shares are trading above their 200-day moving average by 8.48%. Furthermore, shares of the Company, which designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide, have an RSI of 46.60. Get the free research report on VAR at:
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
View original content:http://www.prnewswire.com/news-releases/medical-equipment-stocks-research-reports-released-on-prestige-brands-second-sight-medical-products-senseonics-and-varian-medical-systems-300628795.html
SOURCE Wall St. Equities
Subscribe to our Free Newsletters!
Moringa oleifera has all the essential amino acids, omega oils, vital minerals and vitamins ...
Self-medication is treating self with non-prescription or over the counter medications, for ...
Art of gardening can improve socializing and cognitive skills in children and elderly. As a therapy ...View All